Company / Current Assets
Niagen Bioscience, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$96.8M
FY2025
5-year range
$46.6M / $96.8M
FY2021-FY2025
Trend
+51.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has increased for 3 consecutive years, from $47M in FY2022 to $97M in FY2025.
Based on SEC 10-K filings.
$97M in FY2025 with a 5-year CAGR of +24.6%.
Improved from $50M to $97M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +27.6%
- 5-Year CAGR
- +24.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- Niagen Bioscience, Inc.'s current assets has grown for 3 consecutive years.
- 5-year CAGR of +24.6%, indicating consistent growth.
- In FY2025, current assets increased 51.0% year-over-year.
- Lowest current assets in the period was in FY2016.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $96.8M | +51.0% |
| FY2024 | $64.1M | +29.4% |
| FY2023 | $49.5M | +6.4% |
| FY2022 | $46.6M | -4.8% |
| FY2021 | $48.9M | +51.8% |
| FY2020 | $32.2M | -3.9% |
| FY2019 | $33.5M | -8.3% |
| FY2018 | $36.5M | -36.1% |
| FY2017 | $57.2M | +263.3% |
| FY2016 | $15.7M | -4.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026